PMVP FY 2021 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PMVPPMV Pharmaceuticals, Inc.

$88M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$1M

Operating Income

-$58M

Net Income

-$58M

EPS (Diluted)

$-1.28

Cash Flow

Operating Cash Flow

-$47M

Free Cash Flow

-$48M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$332M

Total Liabilities

$23M

Stockholders' Equity

$309M

Cash & Equivalents

$172M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$1M	-$318,000	-302.8%
Operating Income	-$58M	-$35M	-66.8%
Net Income	-$58M	-$34M	-68.0%